Büyükkaramikli, N. C., Blommestein, H. M., Riemsma, R., Armstrong, N., Clay, F. J., Ross, J., . . . Al, M. J. (2017). Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated with Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics.
Citação norma ChicagoBüyükkaramikli, Nasuh C., et al. "Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated With Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal." Pharmacoeconomics 2017.
Citação norma MLABüyükkaramikli, Nasuh C., et al. "Ramucirumab for Treating Advanced Gastric Cancer or Gastro-Oesophageal Junction Adenocarcinoma Previously Treated With Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal." Pharmacoeconomics 2017.